First Patient Enrolled in PROMISE II U.S. Pivotal Study of LimFlow System to Treat Chronic Limb-Threatening Ischemia

By Natalie GoodridgeDecember 10, 2019October 24th, 2024Healthcare

No Comments

First Patient Enrolled in PROMISE II U.S. Pivotal Study of LimFlow System to Treat Chronic Limb-Threatening Ischemia

https://limflow.com/first-patient-enrolled-in-promise-ii-u-s-pivotal-study-of-limflow-system-to-treat-chronic-limb-threatening-ischemia/

Tags:

Healthcare LimFlow

PreviousCagent Vascular Initiates Enrollment of PRELUDE-BTK Study Using Serranator Device
NextYAHOO Finance On the move: New medical technology could replace stitches, improve recovery for patients

M&L GROUP

We are a family investment firm that cultivates pioneering ventures into successful enterprises with passion, energy and integrity.

Hospitality

Healthcare

Shipping

Alternatives

Media room

About

Contact

Copyright © 2025 M&L Group. All Rights Reserved. | Legal.

Branding and website design by Stepworks